Renatus Tactical Acquisition Corp I - 10-Q Summary
Business Context and Reporting Period
Company: Renatus Tactical Acquisition Corp I (RTAC), a Cayman Islands exempted company and blank check SPAC.
Reporting Period: Quarterly period ended June 30, 2026.
Business Status: The Company has not commenced operations. Activities are limited to formation, the Initial Public Offering (IPO) consummated on May 16, 2025, and the search for a Business Combination. The Company intends to focus on high-potential businesses in the United States.
Capital Structure: 24,150,000 Class A ordinary shares (public) and 7,011,288 Class B ordinary shares (sponsor/founder) outstanding as of August 14, 2026.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2026 | As of June 30, 2026 |
|---|---|---|---|
| Net Income | $1,719,302 | $3,527,862 | - |
| Operating Expenses | $386,381 | $669,295 | - |
| Interest Income (Trust) | $2,105,683 | $4,197,157 | - |
| Cash (Operating) | - | - | $477 |
| Cash Held in Trust | - | - | $252,380,649 |
| Working Capital | - | - | $179,443 |
| Total Liabilities | - | - | $10,938,190 |
| Convertible Notes Outstanding | - | - | $630,000 |
| Deferred Underwriting Fee | - | - | $8,452,500 |
Material Changes vs. Prior Period
- Net Income Increase: Net income for the three months ended June 30, 2026, was $1.72 million, compared to $0.79 million for the same period in 2025. This increase is primarily driven by higher interest income earned on the Trust Account ($2.11 million vs. $1.24 million).
- Expense Reduction: Formation and operating expenses decreased to $386,381 for the three months ended June 30, 2026, from $445,972 in the prior year period.
- Debt Issuance: The Company issued new convertible notes during the period. Total convertible notes outstanding increased from $250,000 at December 31, 2025, to $630,000 at June 30, 2026, following issuances in January and April 2026.
- Trust Account Growth: Cash held in the Trust Account increased by approximately $4.2 million to $252.38 million, reflecting accrued interest income.
Outlook, Risks, and Management Commentary
- Going Concern: Management has raised substantial doubt about the Company's ability to continue as a going concern. With only $477 in operating cash and significant ongoing costs, the Company anticipates it will not have sufficient funds to operate for the next twelve months without additional financing or a Business Combination.
- Deadline: The Company must complete a Business Combination by May 16, 2027 (24 months from IPO), or it may extend the period by up to six months in three-month increments. If no combination is completed, the Company will liquidate and redeem public shares.
- Liquidity Strategy: To fund working capital deficiencies, the Sponsor or affiliates may provide "Working Capital Loans" (up to $1.5 million convertible into shares) or the Company may issue additional securities. No proceeds from the Trust Account will be used to repay these loans unless a Business Combination is consummated.
- Risks: Risks include the inability to complete a Business Combination, market volatility due to geopolitical conflicts (Russia-Ukraine, Middle East), and the potential for the Sponsor to be unable to satisfy indemnification obligations if third-party claims reduce Trust Account funds.
Investor Verification Checklist
- Operating Cash Runway: Verify the sufficiency of the $477 operating cash balance against the monthly administrative fee ($26,000) and other operating costs to confirm the timeline for potential liquidation or need for bridge financing.
- Convertible Note Terms: Review the specific conversion prices ($5.00 for earlier notes, $3.00 for April 2026 notes) and interest rates (0% vs 8%) to assess potential dilution upon a Business Combination.
- Trust Account Yield: Monitor the interest rate environment affecting the Trust Account, which currently holds over $252 million and is the primary source of net income.
- Extension Options: Confirm the specific conditions and shareholder approval requirements for extending the Business Combination deadline beyond May 16, 2027.
- Deferred Fees: Note the $8.45 million deferred underwriting fee payable only upon a successful Business Combination, which reduces net proceeds available to the combined entity.